Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Carcinoma, Epidermoid

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cappelaere, P; Chauvergne, J; Chevallier, B; Chollet, P; Degardin, M; Lentz, MA; Mayer, F1

Trials

1 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Carcinoma, Epidermoid

ArticleYear
Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC Clinical Screening Group.
    European journal of cancer. Part B, Oral oncology, 1995, Volume: 31B, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitrosourea Compounds

1995